Dafna Capital Management LLC Eloxx Pharmaceuticals, Inc. Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$1.56 - $3.65 $298,730 - $698,953
-191,494 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$1.96 - $7.96 $28,088 - $114,074
-14,331 Reduced 6.96%
191,494 $375,000
Q4 2019

Feb 14, 2020
SELL
$3.19 - $7.56 $539,668 - $1.28 Million
-169,175 Reduced 45.11%
205,825 $1.52 Million
Q2 2019

Aug 14, 2019
BUY
$8.77 - $12.49 $3.29 Million - $4.68 Million
375,000 New
375,000 $3.74 Million

About Eloxx Pharmaceuticals, Inc.

ELOX Quotes by TradingView
  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email